James E. Maynard

9.1k citations

152 papers · 6.7k indexed · 2 hit papers · h-index 46

Impact in

Hepatology top 0.1%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
Epidemiology top 0.2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in ⓘ

Hepatology 79
- Hepatitis Viruses Studies and Epidemiology 56
- Hepatitis C virus research 40
Epidemiology 101
- Hepatitis B Virus Studies 87
- Liver Disease Diagnosis and Treatment 24

Co-authors: Daniel W. Bradley (43 shared papers)Stephen C. Hadler (15 shared papers)James W. Ebert (18 shared papers)Edwin H. Cook (17 shared papers)Karen A. McCaustland (16 shared papers)Thomas R. Bender (7 shared papers)Donald P. Francis (7 shared papers)Howard A. Fields (22 shared papers)
Journals: American Journal of Epidemiology (19 papers)The Journal of Infectious Diseases (16 papers)Journal of Medical Virology (12 papers)Journal of Clinical Microbiology (9 papers)Infection and Immunity (6 papers)
Partner nations: United States Australia Canada

In The Last Decade

James E. Maynard

148 papers receiving 5.8k citations

Hit Papers

align trajectories log scale

Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men 1986 · 502 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1986 New England Journal of Medicine
1985 The Journal of Infectious Diseases

Peers

Countries citing papers authored by James E. Maynard

Since Specialization

Citations

This map shows the geographic impact of James E. Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Maynard more than expected).

Fields of papers citing papers by James E. Maynard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Maynard. The network helps show where James E. Maynard may publish in the future.

Co-authors

The 25 scholars most cited alongside James E. Maynard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James E. Maynard Line = papers co-authored together James E. Maynard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Acute Hepatitis B Virus Infection: Relation of Age to the Clinical Expression of Disease and Subsequent Development of the Carrier State The Journal of Infectious Diseases ·B. J. McMahon, Wallace L.M. Alward, D. B. Hall, W. L. Heyward, Thomas R. Bender, D. P. Francis, James E. Maynard Hit paper breakdown →	1985	593
2	Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men New England Journal of Medicine ·Stephen C. Hadler, Donald P. Francis, James E. Maynard, Sumner E. Thompson, Franklyn N. Judson, Dean F. Echenberg, David G. Ostrow, Paul M. OʼMalley, Kent A. Penley, Norman L. Altman, E. H. Braff, Gregory F. Shipman, Patrick J. Coleman, Eric J. Mandel Hit paper breakdown →	1986	502
3	Hepatitis B: global importance and need for control Vaccine ·James E. Maynard	1990	274
4	Hepatitis A in Day-Care Centers New England Journal of Medicine ·Stephen C. Hadler, Hannah Webster, J Erben, Judith E. Swanson, James E. Maynard	1980	209
5	Posttransfusion Non-A, Non-B Hepatitis: Physicochemical Properties of Two Distinct Agents The Journal of Infectious Diseases ·Daniel W. Bradley, James E. Maynard, Hans Pópper, Edwin H. Cook, James W. Ebert, Karen A. McCaustland, Charles A. Schable, Howard A. Fields	1983	167
6	Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles. Proceedings of the National Academy of Sciences ·Daniel W. Bradley, K. Krawczyński, Edwin H. Cook, Karen A. McCaustland, Charles D. Humphrey, John Spelbring, H. Myint, James E. Maynard	1987	163
7	Prevention of Perinatal Acquisition of Hepatitis B Virus Carriage Using Vaccine: Preliminary Report of a Randomized, Double-Blind Placebo-Controlled and Comparative Trial PEDIATRICS ·Zhiyi Xu, Chung-Bo Liu, Donald P. Francis, Robert H. Purcell, Zhi-Li Gun, Shu-Cheng Duan, Rujun Chen, Harold S. Margolis, Chen-hsiang Huang, James E. Maynard, (unknown)	1985	153
8	Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial The Lancet ·Bradford D. Gessner, Agustinus Sutanto, Mary Linehan, I Gusti Gede Djelantik, Tracy Fletcher, I Komang Gerudug, Ingerani, David Mercer, Vanda Moniaga, Lawrence H. Moulton, Kim Mulholland, Carib Nelson, Soewignjo Soemohardjo, Mark C. Steinhoff, Anton Widjaya, P Stoeckel, James E. Maynard, Soemarjati Arjoso	2005	134
9	Global Control of Hepatitis B Through Vaccination: Role of Hepatitis B Vaccine in the Expanded Programme on Immunization Clinical Infectious Diseases ·James E. Maynard, Mark Kane, Stephen C. Hadler	1989	123
10	EPIDEMIOLOGY OF HEPATITIS B IN HOSPITAL PERSONNEL American Journal of Epidemiology ·Charles P. Pattison, James E. Maynard, Kenneth R. Berquist, Hannah Webster	1975	114
11	Experimental infection of chimpanzees with antihemophilic (factor viii) materials: Recovery of virus‐like particles associated with non‐A, non‐B hepatitis Journal of Medical Virology ·Daniel W. Bradley, Edwin H. Cook, James E. Maynard, Karen A. McCaustland, James W. Ebert, Gary H. Dolana, Robert A. Petzel, Robert J. Kantor, Alfred Heilbrunn, Howard A. Fields, Bert L. Murphy	1979	105
12	Occupational Risk of Hepatitis B Infection in Hospital Workers Infection Control ·Stephen C. Hadler, Irene L. Doto, James E. Maynard, Joseph L. Smith, Brian T. Clark, James W. Mosley, Theodore C. Eickhoff, C. K. Himmelsbach, William R. Cole	1985	105
13	Occurrence of hepatitis A, B, and non-A/non-B in the United States The American Journal of Medicine ·Donald P. Francis, Stephen C. Hadler, Thomas J. Prendergast, Evelyn Peterson, Michele Ginsberg, Cindy Lookabaugh, J. Richard Holmes, James E. Maynard	1984	104
14	THE EFFECT OF UNDERREPORTING ON THE APPARENT INCIDENCE AND EPIDEMIOLOGY OF ACUTE VHIAL HEPATITIS American Journal of Epidemiology ·Miriam J. Alter, Allene Mares, Stephen C. Hadler, James E. Maynard	1987	103
15	The introduction of new vaccines into developing countries Vaccine ·R. T. Mahoney, James E. Maynard	1999	102
16	Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus. PubMed ·Daniel W. Bradley, Karen A. McCaustland, Edwin H. Cook, Charles A. Schable, James W. Ebert, James E. Maynard	1985	101
17	Detection of Hepatitis a Viral Antigen by Radioimmunoassay The Journal of Immunology ·F. Blaine Hollinger, Daniel W. Bradley, James E. Maynard, Gordon R. Dreesman, Joseph L. Melnick	1975	90
18	Posttransfusion non-A, non-B hepatitis in chimpanzees Gastroenterology ·Daniel W. Bradley, Karen A. McCaustland, Edwin H. Cook, Charles A. Schable, James W. Ebert, James E. Maynard	1985	89
19	Impact of Infection Control Strategies on the Incidence of Dialysis-Associated Hepatitis in the United States The Journal of Infectious Diseases ·M J Alter, Martin S. Favero, James E. Maynard	1986	84
20	Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages Applied and Environmental Microbiology ·Norman J. Petersen, D. H. Barrett, Walter W. Bond, K. R. Berquist, Martin S. Favero, Thomas R. Bender, James E. Maynard	1976	79

About James E. Maynard

James E. Maynard is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Health and Small Animals, having authored 152 papers that have together received 6.7k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (87 papers), Hepatitis Viruses Studies and Epidemiology (56 papers), Hepatitis C virus research (40 papers), Viral gastroenteritis research and epidemiology (31 papers), Liver Disease Diagnosis and Treatment (24 papers), Vaccine Coverage and Hesitancy (10 papers), Animal Virus Infections Studies (7 papers) and Viral Infections and Immunology Research (7 papers). The work is most often cited by research in Hepatology (4.3k citations), Epidemiology (4.8k citations), Infectious Diseases (1.8k citations), Health (579 citations) and Microbiology (241 citations). James E. Maynard has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Daniel W. Bradley, Stephen C. Hadler, James W. Ebert, Edwin H. Cook, Karen A. McCaustland, Thomas R. Bender, Donald P. Francis, Howard A. Fields, D. P. Francis and Wallace L.M. Alward. Their work appears in journals such as American Journal of Epidemiology, The Journal of Infectious Diseases, Journal of Medical Virology, Journal of Clinical Microbiology and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact